These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34419073)
1. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway. Wu Y; Lin Y; Pan J; Tu X; Xu Y; Li H; Chen Y Cancer Cell Int; 2021 Aug; 21(1):443. PubMed ID: 34419073 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma. Wang X; Tian X; Sui X; Li X; Zhao X; Han K; Sun L; Dong Y Bioengineered; 2022 Mar; 13(3):6113-6125. PubMed ID: 35254214 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway. Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J Gene; 2021 Jan; 766():145163. PubMed ID: 32980450 [TBL] [Abstract][Full Text] [Related]
4. AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma. Bao J; Wu Y; Zhang K; Qi H Int J Gen Med; 2022; 15():6917-6930. PubMed ID: 36061963 [TBL] [Abstract][Full Text] [Related]
5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
6. NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the Wnt/β-catenin signaling pathway. Shi Y; Ge C; Fang D; Wei W; Li L; Wei Q; Yu H Cancer Cell Int; 2022 Mar; 22(1):119. PubMed ID: 35292013 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of NCAPG mediated by E2F1 facilitates the progression of osteosarcoma through the Wnt/β-catenin signaling pathway. Luo G; Cheng H; Fan J; Sun T Transl Cancer Res; 2024 May; 13(5):2437-2450. PubMed ID: 38881929 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
9. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation. Deng H; Hang Q; Shen D; Zhang Y; Chen M Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221 [TBL] [Abstract][Full Text] [Related]
10. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis. Zhang Z; Qi D; Liu X; Kang P Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
12. Fucosyltransferase 2 induced epithelial-mesenchymal transition via TGF-β/Smad signaling pathway in lung adenocarcinaoma. Deng G; Chen L; Zhang Y; Fan S; Li W; Lu J; Chen X Exp Cell Res; 2018 Sep; 370(2):613-622. PubMed ID: 30031128 [TBL] [Abstract][Full Text] [Related]
13. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047 [No Abstract] [Full Text] [Related]
14. GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway. Wang J; Xu M; Li DD; Abudukelimu W; Zhou XH Open Med (Wars); 2021; 16(1):24-32. PubMed ID: 33364431 [TBL] [Abstract][Full Text] [Related]
15. Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer. Xu T; Dong M; Wang Z; Li H; Li X Cancer Manag Res; 2020; 12():5773-5786. PubMed ID: 32765080 [TBL] [Abstract][Full Text] [Related]
16. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses. Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220 [TBL] [Abstract][Full Text] [Related]
17. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway. Zhang T; Xia W; Song X; Mao Q; Huang X; Chen B; Liang Y; Wang H; Chen Y; Yu X; Zhang Z; Yang W; Xu L; Dong G; Jiang F J Hematol Oncol; 2022 Aug; 15(1):114. PubMed ID: 35982471 [TBL] [Abstract][Full Text] [Related]
18. DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma. Fan W; Xing Y; Yan S; Liu W; Ning J; Tian F; Wang X; Zhan Y; Luo L; Cao M; Huang J; Cai L Cancer Cell Int; 2024 Jun; 24(1):208. PubMed ID: 38872157 [TBL] [Abstract][Full Text] [Related]
19. Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis. Chen Y; Jin L; Jiang Z; Liu S; Feng W Front Oncol; 2021; 11():644426. PubMed ID: 33937050 [TBL] [Abstract][Full Text] [Related]
20. PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway. Wang S; Li Y; Jin K; Suda K; Li R; Zhang H; Tian H Transl Lung Cancer Res; 2024 Jun; 13(6):1331-1345. PubMed ID: 38973962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]